comparemela.com

Latest Breaking News On - Insider activity at eyepoint pharmaceuticals - Page 2 : comparemela.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $24.40

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $24.40
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Darioa-paggiarino
Toth-financial-advisory-corp
Investment-advisers
Nasdaq
Jpmorgan-chase-co
Insider-activity-at-eyepoint-pharmaceuticals
News-ratings-for-eyepoint-pharmaceuticals-daily
Tower-research-capital
Eyepoint-pharmaceuticals-stock-down
Schonfeld-strategic-advisors
Eyepoint-pharmaceuticals

EyePoint Pharmaceuticals (NASDAQ:EYPT) Coverage Initiated at JPMorgan Chase & Co.

Investment analysts at JPMorgan Chase & Co. assumed coverage on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) in a report issued on Monday, MarketBeat reports. The firm set an “overweight” rating and a $35.00 price target on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 40.51% from the […]

Eyepoint-pharmaceuticals-company-profile
Insider-activity-at-eyepoint-pharmaceuticals
Schonfeld-strategic-advisors
Barclays-plc
Eyepoint-pharmaceuticals-price-performance
News-ratings-for-eyepoint-pharmaceuticals-daily
Analyst-recommendations-for-eyepoint-pharmaceuticals
Securities-exchange-commission
Toth-financial-advisory-corp
Hedge-funds-weigh-in-on-eyepoint-pharmaceuticals
Investment-advisers

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 5%

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report)’s share price dropped 5% during trading on Tuesday . The stock traded as low as $18.60 and last traded at $18.97. Approximately 170,137 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 780,024 shares. The stock had previously closed at […]

Toth-financial-advisory-corp
Tower-research-capital
Eyepoint-pharmaceuticals-company-profile
Insider-activity-at-eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-price-performance
Cantor-fitzgerald
Nasdaq
Eyepoint-pharmaceuticals
Barclays-plc
News-ratings-for-eyepoint-pharmaceuticals-daily
Lazard-asset-management

EyePoint Pharmaceuticals (NASDAQ:EYPT) Receives "Overweight" Rating from Cantor Fitzgerald

EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $31.00 target price on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 207.23% from the company’s current […]

China
United-kingdom
United-states
Eyepoint-pharmaceuticals-inc
News-ratings-for-eyepoint-pharmaceuticals-daily
Citigroup-inc
Cantor-fitzgerald
Eyepoint-pharmaceuticals
Insider-activity-at-eyepoint-pharmaceuticals
Analyst-recommendations-for-eyepoint-pharmaceuticals
Tower-research-capital

vimarsana © 2020. All Rights Reserved.